Frailty is a predictor for worse outcomes in patients hospitalized with Clostridioides difficile infection

被引:2
|
作者
Chaar, Abdelkader [1 ]
Yoo, Jin Woo [1 ]
Nawaz, Ahmad [1 ]
Rizwan, Rabia [1 ]
Agha, Osama Qasim [1 ]
Feuerstadt, Paul
机构
[1] Yale Sch Med, New Haven, CT USA
来源
ANNALS OF GASTROENTEROLOGY | 2024年 / 37卷 / 04期
关键词
Clostridioides difficile; colitis; frailty; Hospital Frailty Risk Score;
D O I
10.20524/aog.2024.0898
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Frailty has major health implications for affected patients and is widely used in the perioperative risk assessment. The Hospital Frailty Risk Score (HFRS) is a validated score that utilizes administrative billing data to identify patients at higher risk because of frailty. We investigated the utility of the HFRS in patients with Clostridioides difficile infection (CDI) to determine whether they were at risk for worse outcomes and higher healthcare resource utilization. Methods Using the 2017 National Inpatient Sample, we identified all adults with a primary diagnosis of CDI. We classified patients into 2 groups: those who had an HFRS <5 (NonFrailCDI) and those with a score >= 5 (FrailCDI). We assessed differences in hospital outcomes and healthcare resource utilization based on frailty status. Results We identified 93,810 hospitalizations, of which 54,300 (57.88%) were FrailCDI. FrailCDI patients were at higher risk for fulminant CDI (odds ratio [OR] 1.9, 95% confidence interval [CI] 1.6-2.3), requiring colectomy (OR 4.1, 95%CI 1.5-11.2), and inpatient mortality (OR 4.5, 95%CI 2.8-7.1). Furthermore, FrailCDI patients had higher odds of requiring Intensive Care Unit admission (OR 13.7, 95%CI 6.3-29.9) or transfer to another facility on discharge (OR 2.2, 95%CI 2.0-2.4), and had longer hospital stays and higher total charges when compared with NonFrailCDI. Conclusions Frailty as defined by the HFRS is an independent factor for worse outcomes and higher healthcare utilization in adults admitted for CDI. Risk stratifying patients by frailty may improve outcomes.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 50 条
  • [41] Strategies to prevent adverse outcomes following Clostridioides difficile infection in the elderly
    Rauseo, Adriana M.
    Olsen, Margaret A.
    Reske, Kimberly A.
    Dubberke, Erik R.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (03) : 203 - 217
  • [42] Higher mortality rates associated with Clostridioides difficile infection in hospitalized children with cystic fibrosis
    Santhanam, Prathipa
    Egberg, Matthew
    Kappelman, Michael D.
    PEDIATRIC PULMONOLOGY, 2023, 58 (02) : 484 - 491
  • [43] A Retrospective Assessment of Guideline Adherence and Treatment Outcomes From Clostridioides difficile Infection Following the IDSA 2021 Clinical Guideline Update: Clostridioides difficile Infection
    Dubberke, Erik R.
    Li, Qinghua
    Obi, Engels N.
    Turzhitsky, Vladimir
    Siddiqui, Fakhar
    Nathanson, Brian H.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (10):
  • [44] Association Between Bisphosphonates and Hospitalized Clostridioides difficile Infection Among Frail Older Adults
    McConeghy, Kevin W.
    Zullo, Andrew R.
    Lary, Christine W.
    Zhang, Tingting
    Lee, Yoojin
    Daiello, Lori
    Kiel, Douglas P.
    Berry, Sarah
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (05) : 688 - 691
  • [45] Clostridioides difficile Infection among Cirrhotic Patients with Variceal Bleeding
    Voicu, Mirela Nicoleta
    Popescu, Florica
    Florescu, Dan Nicolae
    Rogoveanu, Ion
    Turcu-Stiolica, Adina
    Gheonea, Dan Ionut
    Iovanescu, Vlad Florin
    Iordache, Sevastita
    Cazacu, Sergiu Marian
    Ungureanu, Bogdan Silviu
    ANTIBIOTICS-BASEL, 2021, 10 (06):
  • [46] The Importance of Abnormal Platelet Count in Patients with Clostridioides difficile Infection
    Buchrits, Shira
    Gafter-Gvili, Anat
    Bishara, Jihad
    Atamna, Alaa
    Ayada, Gida
    Eynath, Yair
    Avni, Tomer
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [47] Impact of Clostridioides difficile infection in patients admitted with ulcerative colitis
    Gros, Beatriz
    Soto, Pilar
    Causse, Manuel
    Marin, Sandra
    Iglesias, Eva
    Manuel Benitez, Jose
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2023, 58 (03) : 232 - 239
  • [48] Bezlotoxumab in Patients with a Primary Clostridioides difficile Infection: A Literature Review
    Granata, Guido
    Schiavone, Francesco
    Pipitone, Giuseppe
    ANTIBIOTICS-BASEL, 2022, 11 (11):
  • [49] A genomic survey of Clostridioides difficile isolates from hospitalized patients in Melbourne, Australia
    Larcombe, Sarah
    Williams, Galain C.
    Amy, Jacob
    Lim, Su Chen
    Riley, Thomas V.
    Muleta, Anthony
    Barugahare, Adele A.
    Powell, David R.
    Johanesen, Priscilla A.
    Cheng, Allen C.
    Peleg, Anton Y.
    Lyras, Dena
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
  • [50] Screening for Asymptomatic Clostridioides difficile Carriage Among Hospitalized Patients: A Narrative Review
    Gilboa, Mayan
    Baharav, Nadav
    Melzer, Eyal
    Regev-Yochay, Gili
    Yahav, Dafna
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (09) : 2223 - 2240